In an ever-evolving pharmaceutical landscape, ensuring a seamless transition from development to industrial-scale manufacturing is a major challenge. Service fragmentation, lack of integration between development and production, and uncertainties regarding costs and technical feasibility—these are all obstacles that can delay your projects, increase risks, and drive up expenses.
How can you secure a smooth and optimized process from development to commercialization?
During this webinar, our experts will introduce Fareva’s unique approach as an integrated CDMO, simplifying the transition from pharmaceutical development to manufacturing with a comprehensive offering and centralized project management.
Key Details :
🗓️ April 24, 2024
⏰ 10:00 AM (ET)
Our speakers :
👨⚕️ Philippe Rampignon, VP Pharmaceutical Development & NPI
👩⚕️ Aude Remond, Corporate Quality Assurance Director – Pharma & API
What You Will Learn
- The limitations of traditional approaches: How fragmented services can impact your timelines and budget
- The benefits of an integrated CDMO: How Fareva ensures a smooth transition between development and production through its three GMP pilot sites and fifteen manufacturing facilities
- Our specialized expertise: High-potency oral solid dose development, sterile manufacturing, and biologics
- A real-world case study: The rapid transfer of an mRNA vaccine—an example of technical expertise and responsiveness
Why Attend This Webinar?
- Gain a clear understanding of how an integrated CDMO can simplify your projects and reduce risks
- Discover innovative solutions to accelerate your product’s time-to-market
- Engage with our experts and ask your questions live
Don't miss this opportunity to learn more about Fareva’s development-driven approach and how it can benefit your pharmaceutical projects.